Skip to ContentSkip to Navigation
About us Latest news News

NWO Impact Explorer for Van den Bogaart’s research into the early detection of small amounts of dividing cancer cells in blood

08 February 2024
decorative image
Geert van den Bogaart

Geert van den Bogaart, Professor of Molecular Immunology at the University of Groningen, received an Impact Explorer grant from the Dutch Research Council (NWO). The grant will enable Van den Bogaart to validate the potential societal impact of his research into the early detection of small amounts of dividing cancer cells in blood.

The Impact Explorer programme aims to explore the societal value of an unexpected scientific discovery or insight and is currently a pilot programme. On the basis of its results, it will be decided whether the grant will become structural in the future.

Innovative sensitive test to detect small amounts of dividing cancer cells in blood

Van den Bogaart, his colleague Dr Frans Bianchi, and their teams developed a highly sensitive test to detect very small amounts of dividing cancer cells in biological fluids. The new test overcomes certain limitations of current tests, which are technically complex and expensive or lack sensitivity. It has the potential to improve the accuracy of cancer diagnosis and prevent relapse.

Relevant since small amounts of residual dividing cancer cells can form the beginning or recurrence of a tumor

The new test is important because after cancer treatment, small amounts of cancer cells can remain behind and form the beginning or the recurrence of a tumor. This phenomenon is called minimal residual disease (MRD) and has a huge impact on the survival of cancer patients. MRD testing is particularly important in blood cancers, such as leukaemia and lymphoma, where cancer cells can spread throughout the body via the bloodstream. However, it could potentially also be used to monitor metastases of solid tumors, such as breast cancer or lung cancer, after surgery or chemotherapy.

Next step: assessing effectiveness and feasibility

The research group now aims to assess the effectiveness of the new test and develop a roadmap for its clinical application. Collaborations with academics and industry researchers are planned to obtain initial evidence of feasibility of this test for cancer detection.

More information

Geert van den Bogaart

Last modified:08 February 2024 2.12 p.m.
View this page in: Nederlands

More news

  • 11 June 2024

    Hydrogen seeps into nooks and crannies

    Because hydrogen is a much smaller molecule than natural gas, it can easily leak. Even worse, despite its small size, hydrogen can affect larger materials and make them as brittle as glass.

  • 06 June 2024

    ‘We could not have dreamed of this’

    An international team of researchers, led by Groningen PhD candidate Aditya Arabhavi, has discovered that disks around very faint young stars are very different from those around Sun-like stars.

  • 06 June 2024

    Comenius Teaching Fellow grant for Lerch and Bianchi

    Dr. Michael Lerch and Dr. Frans Bianchi have received a EUR 50,000 Comenius Teaching Fellow grant from the NRO.